XBI vs. XOVR ETF Comparison
Comparison of SPDR S&P Biotech ETF (XBI) to ERShares Private-Public Crossover ETF (XOVR)
XBI
SPDR S&P Biotech ETF
XBI Description
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
Grade (RS Rating)
Last Trade
$97.51
Average Daily Volume
7,364,590
10
XOVR
ERShares Private-Public Crossover ETF
XOVR Description
Grade (RS Rating)
Last Trade
$16.37
Average Daily Volume
31,444
30
Performance
| Period | XBI | XOVR |
|---|---|---|
| 30 Days | -1.01% | 10.31% |
| 60 Days | 4.38% | 15.77% |
| 90 Days | 6.34% | 3.09% |
| 12 Months | 35.36% | 43.88% |
XBI Underweight 27 Positions Relative to XOVR
| Symbol | Grade | Weight | |
|---|---|---|---|
| META | A | -6.0% | |
| NVDA | B | -5.59% | |
| GOOGL | B | -5.37% | |
| ORCL | A | -4.77% | |
| CRM | B | -4.45% | |
| DASH | A | -4.03% | |
| SPOT | C | -3.88% | |
| RMD | C | -3.78% | |
| ANET | A | -3.59% | |
| CPRT | B | -3.42% | |
| MPWR | B | -3.25% | |
| CPAY | A | -3.17% | |
| MDB | D | -3.17% | |
| APP | A | -3.15% | |
| ABNB | D | -3.05% | |
| SNPS | F | -3.04% | |
| DDOG | B | -2.9% | |
| PCTY | C | -2.69% | |
| ULTA | D | -2.61% | |
| TOST | B | -2.56% | |
| DBX | C | -2.5% | |
| DKNG | C | -2.47% | |
| PSTG | F | -2.16% | |
| APPF | C | -2.15% | |
| MEDP | F | -2.13% | |
| CFLT | F | -1.86% | |
| SMCI | F | -1.71% |
XBI: Top Represented Industries & Keywords
XOVR: Top Represented Industries & Keywords
Compare ETFs
